Table 1.
Persistent Nonusers | Persistent Low‐Cost Users | Persistent Average‐Cost User | Persistent Moderate‐Cost User | Sporadic Low‐to‐High‐Cost Users | Transition to HCU | Transition from HCU | Episodic‐HCU | Persistent‐HCU | |
---|---|---|---|---|---|---|---|---|---|
n | 291,940 | 582,763 | 1,528,344 | 262,407 | 484,024 | 67,989 | 27,670 | 12,841 | 202,785 |
Percentage of study cohort (percent) | 8.4 | 16.8 | 44.2 | 7.6 | 14.0 | 2.0 | 0.8 | 0.4 | 5.9 |
Percentage of total 2011 prescription drug expenditures (%) | 0.0 | 0.3 | 9.9 | 20.5 | 15.8 | 11.0 | 0.4 | 0.2 | 41.9 |
Average prescription drug costs | $0 | $12 | $131 | $1,587 | $663 | $3,266 | $267 | $255 | $4,192 |
Sex (%) | |||||||||
Female | 40 | 42 | 54 | 55 | 56 | 48 | 55 | 55 | 54 |
Age (%) | |||||||||
0–17 | 22 | 31 | 14 | 1 | 3 | 4 | 2 | 3 | 1 |
18–44 | 36 | 40 | 43 | 9 | 25 | 24 | 22 | 38 | 8 |
45–64 | 30 | 25 | 32 | 37 | 42 | 41 | 34 | 39 | 34 |
65–84 | 7 | 4 | 9 | 45 | 26 | 25 | 29 | 16 | 46 |
85+ | 5 | 0 | 1 | 9 | 4 | 5 | 13 | 3 | 10 |
Ethnicity (%) | |||||||||
Chinese surname | 21 | 12 | 10 | 6 | 7 | 6 | 6 | 8 | 4 |
South Asian surname | 2 | 3 | 6 | 3 | 4 | 5 | 3 | 5 | 3 |
Income (%) | |||||||||
Quintile 1 | 15 | 15 | 17 | 30 | 23 | 29 | 26 | 23 | 34 |
Quintile 2 | 23 | 19 | 18 | 19 | 17 | 17 | 20 | 18 | 20 |
Quintile 3 | 23 | 22 | 20 | 15 | 17 | 16 | 17 | 18 | 15 |
Quintile 4 | 21 | 23 | 21 | 16 | 18 | 16 | 17 | 18 | 14 |
Quintile 5 | 16 | 21 | 23 | 20 | 23 | 20 | 18 | 22 | 16 |
Major ADGs (%) | |||||||||
0 | 94 | 88 | 75 | 37 | 54 | 27 | 50 | 49 | 21 |
1–2 | 6 | 12 | 24 | 52 | 41 | 56 | 40 | 45 | 58 |
3+ | 1 | 0 | 1 | 11 | 6 | 16 | 10 | 7 | 20 |
Minor ADGs (%) | |||||||||
0–1 | 85 | 59 | 29 | 8 | 13 | 8 | 26 | 20 | 6 |
2–3 | 12 | 30 | 36 | 27 | 31 | 25 | 29 | 31 | 21 |
4–5 | 3 | 9 | 23 | 30 | 29 | 29 | 23 | 27 | 28 |
6+ | 1 | 2 | 12 | 35 | 27 | 38 | 22 | 22 | 44 |
Death in 2011 Q4 (crude), % | 0.27 | 0.06 | 0.17 | 1.84 | 0.99 | 1.98 | 8.54 | 2.94 | 2.12 |
Death in 2011 Q4 (age‐adjusted), % | 0.28 | 0.27 | 0.34 | 0.80 | 0.70 | 1.46 | 3.48 | 2.72 | 1.03 |
All differences in demographics and spending across prescription drug user groups are statistically significant at p = .001.